Crossmark

Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil

Crossref DOI link: https://doi.org/10.1186/s12876-017-0676-8

Published Online: 2017-11-23

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Perazzo, Hugo

Jorge, Marcelino Jose

Silva, Julio Castro

Avellar, Alexandre Monken

Silva, Patrícia Santos

Romero, Carmen

Veloso, Valdilea Gonçalves

Mujica-Mota, Ruben

Anderson, Rob

Hyde, Chris

Castro, Rodolfo
Funding

Funding for this research was provided by:

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) (E-26/170.021/2015)

Medical Research Council (MR/M026515/1)